Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benralizumab (KHK4563) Phase IIa in uncontrolled eosinophilic asthma
NCT01412736Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Aug 2011
- Primary completion
- Jul 2013
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of benralizumab in eosinophilic asthma (EA), sponsored by Kyowa Kirin. Started Aug 2011; status: completed.
02
Drugs
benralizumab
03
Conditions
eosinophilic asthma (EA)
Beyond the preview
Go deeper on NCT01412736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01412736.